Mr. Nishant Jain Appointed to CCRH’s Re-constituted Special Committee for Drug Standardization
In a major step forward for the homoeopathic fraternity, Mr. Nishant Jain has been chosen as a Non-Official Member of the Re-constituted Special Committee for Drug Standardization (SCDS) under the Central Council for Research in Homoeopathy (CCRH), Ministry of AYUSH, Government of India. This appointment is a major recognition of his persistent work in the field of Homoeopathy particularly with regard to quality standards, research and advancement of homoeopathic pharmaceuticals.
The Special Committee for Drug Standardization has a prominent place in the whole scheme of homoeopathic research and drug quality assurance in India. Its work is helpful in improving uniform standards, assisting scientific evaluation and enhancing the reliability in the preparation and use of homoeopathic medicines. Standardization has emerged as an important area to ensure consistency, reliability and wider acceptance of the homoeopathic products with the sector viewing growing interest nationally and internationally.
Mr. Nishant Jain’s participation in the re-constituted committee is being seen as an important step forward, especially considering his long-standing relationship with the homoeopathic pharmaceutical industry. As, a CEO of BJain Pharmaceuticals, he has been closely associated with the efforts for improving the product quality, promoting research based development and fostering the globalization of Homoeopathy over the years. His field experience is anticipated to bring an industry perspective to the committee’s decisions.
“I sincerely appreciate CCRH and the Ministry of AYUSH for entrusting me with this responsibility,” Mr. Nishant Jain said after the declaration. He also acknowledged the importance of the role saying it is not only an accomplishment in itself but a responsibility for the future growth and scientific reliability of Homoeopathy. His comments showed a willingness to work constructively and collaboratively with his fellow committee members.
the selection is made when the requirement for scientific documentation, quality control and standardized protocols in homoeopathic medicine is being progressively highlighted. Committees such as the SCDS have an important role in guiding conversations that may impact research objectives, quality benchmarks and prospects for the discipline. Involvement of experienced professionals can help to bridge the gap between practical knowledge from industry and academic and regulatory expectations.
The homoeopathic community greeted the news and offered its best regards to Mr Nishant Jain. For many, this position is a positive step for those who are working to improve the fundamentals of Homoeopathy through rigorous research, best practices in manufacturing and dependable standardization.
With this new responsibility, Mr. Nishant Jain’s appointment is expected to add value to the constant attempts toward enhancing the scientific and professional standing of Homoeopathy in India and abroad. Stakeholders who are still working for the growth, acceptance and reputation of homoeopathic medicine at national and global levels will be watching his role in the committee closely.
